← All diseases
Brain and nervous system
Multiple sclerosis (progressive)
Do you want to receive a message when there is new research on Multiple Sclerosis (Progressive)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you see one sentence explaining what was investigated — and you'll be notified as soon as new research on Multiple sclerosis (progressive) is published. View what Premium costs.
Publications and studies (1543)
- Combining Human Genetics of Multiple Sclerosis with Oxidative Stress Phenotype for Drug Repositioning. (2021/12/02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Calcium-phosphate homeostasis in secondary progressive multiple sclerosis patients during mitoxantrone therapy. (2021/12/01) ♡
- The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes. (2021/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Multiple sclerosis and daily care]. (2021/12/01) ♡
- pySuStaIn: a Python implementation of the Subtype and Stage Inference algorithm. (2021/12/01) ♡
- [NEUROPSYCHOLOGICAL ANALYSIS OF DISORDERS OF HIGHER MENTAL FUNCTIONS IN PATIENTS WITH DIFFERENT TYPES OF MULTIPLE SCLEROSIS]. (2021/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cognitive Aspects in Multiple Sclerosis. (2021/12/01) ♡
- Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression. (2021/11/29) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis. (2021/11/26) ♡
- A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination. (2021/11/25) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rhabdomyoma and Hypoplastic Left Heart Syndrome - Case Report of a Very Rare Combination. (2021/11/25) ♡
- Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients. (2021/11/25) ♡
- Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination. (2021/11/23) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Crotalphine Attenuates Pain and Neuroinflammation Induced by Experimental Autoimmune Encephalomyelitis in Mice. (2021/11/22) ♡
- Epigenetic Small Molecules Rescue Nucleocytoplasmic Transport and DNA Damage Phenotypes in C9ORF72 ALS/FTD. (2021/11/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders. (2021/11/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease. (2021/11/18) ♡
- Associations between Lifestyle Behaviors and Quality of Life Differ Based on Multiple Sclerosis Phenotype. (2021/11/17) ♡
- Dietary risk factors of primary progressive multiple sclerosis: A population-based case-control study. (2021/11/01) ♡
- Mutations in the John Cunningham virus VP1 gene could predispose to the development of progressive multifocal leukoencephalopathy in multiple sclerosis patients undergoing treatment with natalizumab. (2021/11/01) ♡
- Sociodemographic and clinical characteristics of diet adherence and relationship with diet quality in an international cohort of people with multiple sclerosis. (2021/11/01) ♡
- An interpretable machine learning model to explain the interplay between brain lesions and cortical atrophy in multiple sclerosis. (2021/11/01) ♡
- Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate. (2021/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cerebrospinal Fluid IgM and Oligoclonal IgG Bands in Multiple Sclerosis: A Meta-Analysis of Prevalence and Prognosis. (2021/10/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective. (2021/10/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients. (2021/10/15) ♡
- Identification of regulatory T cell molecules associated with severity of multiple sclerosis. (2021/10/01) ♡
- A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington. (2021/10/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Effect of nutrition on neurodegenerative diseases. A systematic review. (2021/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A 50 Year-Old Woman with A Delayed Diagnosis of Neuromyelitis Optica Spectrum Disorder: The Clinical Course and Serial Neuroimaging Findings. (2021/09/30) ♡
- Homocysteine as a Predictor Tool in Multiple Sclerosis. (2021/09/28) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Efficacy of high-intensity aerobic exercise on cognitive performance in people with multiple sclerosis: A randomized controlled trial. (2021/09/01) ♡
- Cyclophosphamide treatment in active multiple sclerosis. (2021/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc. (2021/09/01) ♡
- Effects of behavioural therapy versus interferential current on bladder dysfunction in multiple sclerosis patients; a randomised clinical study. (2021/09/01) ♡
- Efficacy and Safety of Rituximab in Central Nervous System Demyelinating Disorders. (2021/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oligodendrocytes, BK channels and the preservation of myelin. (2021/08/09) ♡
- Chitinase 3-like 1 is not a target antigen in patients with multiple sclerosis. (2021/08/01) ♡
- Reduction in Fatigue Symptoms Following the Administration of Nutritional Supplements in Patients with Multiple Sclerosis. (2021/07/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer's Disease. (2021/07/20) ♡
- N-acetyl cysteine administration affects cerebral blood flow as measured by arterial spin labeling MRI in patients with multiple sclerosis. (2021/07/16) ♡
- Accurate classification of secondary progression in multiple sclerosis using a decision tree. (2021/07/01) ♡
- Expanding spectrum of opportunistic infections associated with dimethyl fumarate. (2021/07/01) ♡
- Delayed diagnosis of multiple sclerosis in a low prevalence country. (2021/07/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. A controlled trial of two mind-body interventions for grief in widows and widowers. (2021/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Extracellular vesicles (exosomes and ectosomes) play key roles in the pathology of brain diseases. (2021/06/20) ♡
- Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis. (2021/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis. (2021/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England: a review comparing the assessment by HAS and NICE. (2021/06/01) ♡
- Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the "no evidence of disease activity" parameter. (2021/06/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.